1. JAK inhibitors increase risk of thrombosis, MI, stroke, cancer and death

   News item 24 September 2022 Pages: 1 - 1

2. Mycophenolate mofetil-related acute inflammatory syndrome

   News item 24 September 2022 Pages: 2 - 2

3. Novavax COVID-19 vaccine-related myocarditis and pericarditis

   News item 24 September 2022 Pages: 3 - 3

4. Potential lead poisoning with Penisole Ayurvedic medicine

   News item 24 September 2022 Pages: 4 - 4

5. Sitagliptin may be contaminated with nitrosamine impurity

   News item 24 September 2022 Pages: 5 - 5

6. ZOLGENSMA-related fatal acute liver failure

   News item 24 September 2022 Pages: 6 - 6

7. ADRs in paediatric patients differ between age groups and sexes

   Clinical study 24 September 2022 Pages: 7 - 7

8. BCG vaccine-related complications in infants with CID

   Clinical study 24 September 2022 Pages: 8 - 8

9. Long-term antidepressant use increases risk of CHD and death

   Clinical study 24 September 2022 Pages: 9 - 9

10. Myocardial injury after 4th dose of Pfizer-BioNTech COVID-19 vaccine

    Clinical study 24 September 2022 Pages: 10 - 10

11. PD-1 inhibitors cause ILD in NSCLC patients with hypertension

    Clinical study 24 September 2022 Pages: 11 - 11

12. Side effects common after first dose of COVID-19 vaccine: a survey from Spain

    Clinical study 24 September 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 24 September 2022 Pages: 13 - 13

14. Abatacept/secukinumab/tocilizumab

    Case report 24 September 2022 Pages: 14 - 14

15. Abemaciclib/aspirin/enoxaparin sodium

    Case report 24 September 2022 Pages: 15 - 15

16. Acalabrutinib

    Case report 24 September 2022 Pages: 16 - 16

17. Acetylcholine

    Case report 24 September 2022 Pages: 17 - 17

18. Aciclovir/tacrolimus/vancomycin

    Case report 24 September 2022 Pages: 18 - 18

19. Aciclovir/valganciclovir

    Case report 24 September 2022 Pages: 19 - 19

20. Ad26.COV2-S

    Case report 24 September 2022 Pages: 20 - 20

21. Adalimumab

    Case report 24 September 2022 Pages: 21 - 21

22. Adalimumab

    Case report 24 September 2022 Pages: 22 - 22

23. Adalimumab

    Case report 24 September 2022 Pages: 23 - 23

24. Adalimumab/infliximab

    Case report 24 September 2022 Pages: 24 - 24

25. Afatinib/crizotinib/erlotinib

    Case report 24 September 2022 Pages: 25 - 25

26. Allopurinol/camrelizumab/carbamazepine

    Case report 24 September 2022 Pages: 26 - 26

27. Alpelisib/empagliflozin/metformin

    Case report 24 September 2022 Pages: 27 - 27

28. Alteplase

    Case report 24 September 2022 Pages: 28 - 28

29. Alteplase

    Case report 24 September 2022 Pages: 29 - 29

30. Amikacin/cefazolin/vancomycin

    Case report 24 September 2022 Pages: 30 - 30

31. Aminolevulinic acid

    Case report 24 September 2022 Pages: 31 - 31

32. Aminolevulinic-acid

    Case report 24 September 2022 Pages: 32 - 32

33. Amiodarone

    Case report 24 September 2022 Pages: 33 - 33

34. Amiodarone/acarbose

    Case report 24 September 2022 Pages: 34 - 34

35. Amiodarone/epinephrine/metoclopramide

    Case report 24 September 2022 Pages: 35 - 35

36. Amitriptyline/venlafaxine

    Case report 24 September 2022 Pages: 36 - 36

37. Amlodipine

    Case report 24 September 2022 Pages: 37 - 37

38. Amphotericin-B liposomal/miltefosine

    Case report 24 September 2022 Pages: 38 - 38

39. Amphotericin-b/clofarabine

    Case report 24 September 2022 Pages: 39 - 39

40. Amphotericin-B/immunosuppressants

    Case report 24 September 2022 Pages: 40 - 40

41. Anabolic steroids abuse

    Case report 24 September 2022 Pages: 41 - 41

42. Anagrelide/aspirin

    Case report 24 September 2022 Pages: 42 - 42

43. Anakinra/tocilizumab

    Case report 24 September 2022 Pages: 43 - 43

44. Anamorelin

    Case report 24 September 2022 Pages: 44 - 44

45. Anti-cd19-car-transduced-t-cells

    Case report 24 September 2022 Pages: 45 - 45

46. Anti-inflammatories/immunosuppressants

    Case report 24 September 2022 Pages: 46 - 46

47. Antibacterials

    Case report 24 September 2022 Pages: 47 - 47

48. Antibacterials

    Case report 24 September 2022 Pages: 48 - 48

49. Antibacterials/oxycodone

    Case report 24 September 2022 Pages: 49 - 49

50. Anticoagulants

    Case report 24 September 2022 Pages: 50 - 50